Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000723105 | SCV002197700 | pathogenic | not provided | 2022-11-22 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with SI-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asp885Valfs*14) in the SI gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SI are known to be pathogenic (PMID: 16329100, 23103650, 25452324). |
Fulgent Genetics, |
RCV002499337 | SCV002810369 | likely pathogenic | Sucrase-isomaltase deficiency | 2022-05-24 | criteria provided, single submitter | clinical testing | |
Gharavi Laboratory, |
RCV000723105 | SCV000854236 | uncertain significance | not provided | 2018-09-16 | no assertion criteria provided | research |